Verified peer comparison
Exagen vs Aytu BioPharma Financial Comparison
Direct answer
Exagen and Aytu BioPharma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Exagen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Exagen Revenue
- 66,575,000 USD
- Aytu BioPharma Revenue
- 66,382,000 USD
- Exagen Operating income
- -14,070,000 USD
- Aytu BioPharma Operating income
- -7,827,000 USD